| Quarterly Financials | Jun 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 84 | 72 | 92 | 54 | 63 | 42 | 33 | 22 | 25 | 37 | 56 | 48 | 47 | 53 | 92 | 116 |
| Expenses | 79 | 61 | 81 | 48 | 61 | 47 | 35 | 21 | 28 | 35 | 54 | 44 | 46 | 53 | 87 | 86 |
| EBITDA | 4 | 11 | 10 | 6 | 2 | -5 | -2 | 0 | -3 | 2 | 2 | 3 | 1 | -0 | 5 | 30 |
| Operating Profit % | 5 % | 14 % | 10 % | 7 % | -2 % | -16 % | -15 % | -13 % | -31 % | 2 % | 7 % | 5 % | 0 % | -2 % | 5 % | 25 % |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 4 | 10 | 10 | 6 | 1 | -5 | -3 | -0 | -4 | 2 | 1 | 3 | 0 | -3 | 1 | 26 |
| Tax | 1 | 3 | 2 | 2 | 0 | -2 | -1 | 0 | 1 | -1 | 0 | 1 | 0 | 4 | -1 | 5 |
| Net Profit | 3 | 8 | 8 | 4 | 1 | -4 | -1 | -1 | -5 | 2 | 1 | 2 | 0 | -7 | 2 | 21 |
| EPS in ₹ | 1.65 | 4.70 | 2.41 | 1.31 | 0.24 | -0.81 | -0.33 | -0.13 | -1.09 | 0.54 | 0.16 | 0.42 | 0.04 | -1.30 | 0.32 | 3.89 |
Valiant Laboratories
Valiant Laboratories
99.65
-5.24
(-5.00%)
Market Cap
541.22 Cr
PE Ratio
35.85
Volume
94,454.00
Day High - Low
108.75 - 99.65
52W High-Low
110.70 - 49.51
Key Fundamentals
Market Cap
541.22 Cr
EPS
-0.51
PE Ratio
35.85
PB Ratio
1.85
Book Value
57.24
EBITDA
6.39
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-0.94
Debt to Equity
0.42
Actual
Company News
View All News
Valiant Laboratories reported a standalone net profit of ₹9.48 crore for Q1FY27, a 422% jump YoY, driven by a 44% rise in revenue from operations.
Valiant Labs approves ₹60 Cr VASPL investment
Aug 11, 2026
Aug 11, 2026Valiant Laboratories Limited approved a ₹60 crore investment in its wholly owned subsidiary VASPL via preference shares. The Board also re-appointed key directors and shifted its registered office to Palghar.
Valiant Labs gets GST orderMay 30, 2026
May 30, 2026Valiant Laboratories received a GST order confirming a demand of ₹18 Lakhs with a penalty of ₹18 Lakhs. The company plans to appeal.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,920.00 | #1 4,60,672.31 | 37.63 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 49.73 | |
9,239.00 | 2,45,266.42 | 82.14 | 11,067.00 | 13.95 | 2,568 | 65.50 | 81.03 | |
5,050.00 | 1,92,085.77 | 88.66 | 13,886.20 | 20.34 | 2,138 | 3.28 | 58.64 | |
1,191.00 | 1,19,842.47 | 25.83 | 27,657.90 | 17.64 | 5,026 | -34.90 | 62.92 | |
1,423.50 | 1,14,996.78 | 34.18 | 29,044.60 | 2.24 | 3,870 | -39.18 | 45.53 | |
1,938.50 | 1,04,651.20 | 95.14 | 6,867.80 | 22.01 | 890 | #1 123.93 | 74.73 | |
2,171.50 | 99,288.05 | #1 17.83 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 30.05 | |
2,382.90 | 98,412.81 | 48.28 | 14,636.40 | 14.85 | 1,938 | 29.13 | 42.43 | |
1,178.00 | 98,324.02 | 30.81 | 35,058.60 | 3.90 | 4,158 | -69.10 | 44.77 | |
1,645.30 | 94,666.93 | 25.29 | 34,145.20 | 5.56 | 3,503 | 25.21 | 58.42 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
71.09 %
Net Income Growth
-60.45 %
Cash Flow Change
-30.69 %
ROE
-823.08 %
ROCE
77.27 %
EBITDA Margin (Avg.)
392.59 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 213 | 343 | 401 | 464 |
| Fixed Assets | 48 | 50 | 48 | 233 |
| Current Assets | 151 | 226 | 193 | 228 |
| Capital Work in Progress | 1 | 43 | 156 | 6 |
| Investments | 34 | 38 | 0 | 45 |
| Other Assets | 130 | 212 | 197 | 0 |
| Total Equity & Liabilities | 213 | 343 | 401 | 464 |
| Current Liabilities | 51 | 29 | 60 | 119 |
| Non Current Liabilities | 62 | 77 | 107 | 34 |
| Total Equity | 101 | 237 | 234 | 311 |
| Reserve & Surplus | 68 | 193 | 191 | 257 |
| Share Capital | 33 | 44 | 44 | 54 |
Cash Flow
| Cash Flow | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 11 | -7 |
| Investing Activities | -55 | -144 | -53 |
| Operating Activities | 56 | 2 | 1 |
| Financing Activities | -1 | 152 | 45 |
Share Holding
| % Holding | Sept 2023 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % | 74.94 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 3.48 % | 1.89 % | 0.00 % | 0.00 % | 0.64 % | 0.63 % | 0.52 % | 0.02 % | 0.01 % | 0.20 % | 0.00 % |
| DIIs | 3.89 % | 0.04 % | 0.02 % | 0.03 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.46 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 12.49 % | 12.49 % | 13.36 % | 15.16 % | 16.09 % | 17.30 % | 17.55 % | 16.28 % | 17.05 % | 17.08 % | 18.19 % | 18.51 % | 18.53 % | 18.91 % |
| Others | 8.68 % | 12.53 % | 11.68 % | 6.39 % | 7.07 % | 7.76 % | 7.51 % | 8.13 % | 6.92 % | 7.46 % | 6.85 % | 6.55 % | 6.33 % | 6.15 % |
| No of Share Holders | 37,434 | 37,434 | 15,821 | 14,914 | 14,249 | 15,189 | 15,692 | 15,036 | 14,432 | 14,948 | 15,075 | 14,910 | 14,657 | 14,341 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Aug 2024 |  Annual General Meeting | NA | 08 Aug 2024 | 132.40 | 114.95 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 109.94 | 105.99 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 93.23 | 99.27 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 100.98 | 104.48 |
| 19 Jul 2025 |  Rights | 1:4 | 18 Jul 2025 | 104.70 | 103.20 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 88.15 | 91.32 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 86.49 | 87.83 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 83.50 | 82.59 |
| 11 Feb 2026 | Quarterly Result Announcement | NA | 11 Feb 2026 | 60.99 | 66.42 |
| 14 May 2026 | Quarterly Result Announcement | NA | 14 May 2026 | 81.25 | 79.78 |
| 10 Aug 2026 | Quarterly Result Announcement | NA | 10 Aug 2026 | 63.86 | 64.59 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2026
Aug 12, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 10, 2026
Aug 10, 2026Opening Of A New Corporate Office Of The CompanyAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Change in Registered Office AddressAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-AcquisitionAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateAug 10, 2026
Aug 10, 2026 For Quarter Ended June 30 2026.Aug 10, 2026
Aug 10, 2026Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter Ended June 30 2026.Aug 10, 2026
Aug 10, 2026Board Meeting Intimation for Approval Of Financial Results For Quarter Ended June 30 2026Aug 05, 2026
Aug 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Jul 13, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 30, 2026
May 30, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2026
May 22, 2026Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011May 20, 2026
May 20, 2026Intimation Recieved Under Regulation 10(5) Of SEBI (SAST) Regulations 2011May 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 16, 2026
May 16, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 14, 2026
May 14, 2026Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31 2026.May 14, 2026
May 14, 2026Appointment Of Cost Auditor And Internal AuditorMay 14, 2026
May 14, 2026Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31 2026.May 14, 2026
May 14, 2026Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For Quarter And Year Ended March 31 2026.May 14, 2026
May 14, 2026Board Meeting Intimation for Approval Of Financial Results For Quarter And Year Ended March 31 2026May 11, 2026
May 11, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 23, 2026
Apr 23, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 13, 2026
Apr 13, 2026Closure of Trading WindowMar 26, 2026
Mar 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 11, 2026
Feb 11, 2026Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025.Feb 11, 2026
Feb 11, 2026Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025.Feb 11, 2026
Feb 11, 2026Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended December 31 2025.Feb 06, 2026
Feb 06, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 15, 2026
Jan 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Jan 07, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 26, 2025
Dec 26, 2025Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Nov 13, 2025Board Comments On The Communication Received From The Stock ExchangesNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 11, 2025
Nov 11, 2025Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 11, 2025
Nov 11, 2025Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2025
Nov 07, 2025Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended September 302025.Nov 06, 2025
Nov 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 25, 2025
Sep 25, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Technical Indicators
RSI(14)
Neutral 73.04
ATR(14)
Volatile 4.86
STOCH(9,6)
Overbought 86.44
STOCH RSI(14)
Neutral 59.31
MACD(12,26)
Bullish 2.13
ADX(14)
Very Strong Trend 62.22
UO(9)
Bearish 62.09
ROC(12)
Uptrend And Accelerating 33.29
WillR(14)
Neutral -27.97
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
